Colon and Rectum Carcinoma Surveillance Counterpoint: Australia
Surveillance for colorectal cancer should aim to identify recurrence at a point when therapy, in the form of surgery and/or adjuvant therapy, could impact survival duration and/or quality of life (QOL). The identification of metachronous neoplasms and early diagnosis of other conditions also improves overall survival duration . Standardized surveillance strategies are also important to provide information to drive quality improvement through audit of outcomes against professional and national standards.
KeywordsAustralia Postoperative Recurrence Surveillance Therapy
- 2.National Health and Medical Research Council (NHMRC). Clinical practice guidelines for the Prevention, early detection and management of colorectal cancer. The Cancer Council Australia, Australian Cancer Network, The Commonwealth of Australia, Canberra 2005.Google Scholar
- 6.Raptis DA, Gore DM, Boulos PB. The value of CEA and CT in early diagnosis of colorectal cancer recurrence. American Society of Colon and Rectal Surgeons Tripartite Meeting 2008. Oral presentation. Boston 2008.Google Scholar
- 17.Hara M, Kanemitsu Y, Hirai T, Komori K, Kato T. Negative Serum CEA has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and post test probability in a follow-up study. Dis Colon Rectum. 2008;51:1675–80.PubMedCrossRefGoogle Scholar
- 24.Primrose J, Mant D. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patient who have undergone resection for colorectal cancer with curative intent. A protocol. Website -http://www.controlled-trials.com/isrctn/pf/61091474.